My PCR
Create Account
Logo PCR

ST-segment elevation myocardial infarction (STEMI)

Latest STEMI content in interventional cardiology - research, practice, and education

Treating STEMI brings into play a series of clinical and organisational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well…

Filtered By
STEMI

412 results

Clinical cases - Coronary interventions - Session 1

06 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 3

06 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 2

06 Oct 2022 – From AICT-AsiaPCR 2022

PCRonline @ TCT 2022 - Get the international perspective!

12 Sep 2022

Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2022 - check out the list here!

PCRonline @ TCT 2022 - get the international perspective!

How should I treat a STEMI - A patient's journey - With Angola & Sudan

02 Sep 2022

Watch the replay of #AfricaPCR 2022’s live webinar on STEMI.

How should I treat a STEMI - A patient's journey - With Angola & Sudan

Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

01 Sep 2022

Daniele Giacoppo analyses the results of the SCAAR registry which compared patients with STEMI treated by primary PCI in Sweden from January 2008 to December 2016 according to the UFH pretreatment status...

Daniele Giacoppo

Author

Daniele Giacoppo
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Durable polymer vs. biodegradable polymer DES in patients with ACS undergoing complex PCI: A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial

30 Aug 2022

The HOST-REDUCE-POLYTECH-ACS trial was a randomised, parallel-group multicentre trial with a 2x2 factorial design testing two independent hypotheses, one of which was the non-inferiority of durable polymer drug-eluting stents (DP-DES) to biodegradable polymer drug-eluting stents (BP-DES) in patients with ACS. In this post-hoc analysis, the authors...

Nicola Ryan

Reviewer

Nicola Ryan
A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial

How should I treat a patient at high-bleeding risk requiring complex distal Left Main PCI for ACS ?

17 Jun 2021

Discover the replay of this webinar on high bleeding risk and complex PCI, with E. Barbato, B. Chevalier, A. Chieffo and T. Cuisset

How should I treat a patient at high-bleeding risk requiring complex PCI?

How to use invasive coronary physiology in ACS patients?

23 Sep 2021

Watch the replay of this webinar on coronary physiology with F. Alfonso, T. Engstrom, T. Keeble and R. Kharbanda

How to use invasive coronary physiology in ACS patients?

A lethal combination. simultaneous inferior and anterior STEMI with aborted sudden cardiac death and cardiogenic shock

11 Aug 2022

View this case of a 60-year-old male with hypertension as a modifiable cardiovascular risk factor. A history of thoracic surgery for a gunshot wound 40 years ago and no cardiovascular history.

Authors :

Juan Guzmán Olea, Miguel Ángel Gómez Pluma, Gabriel Guzmán Olea, Juan Francisco Rodríguez Alvarado, Leticia Arizbeth Hernández Castro, Gonzalo Tolosa Dzul, Carlos Javier González Álvarez, Héctor Hugo Escutia Cuevas, Daniel Iván Pérez Vásquez
A lethal combination. Simultaneous inferior and anterior STEMI with aborted sudden cardiac death and cardiogenic shock